Markedsdata leveret af TwelveData og Morningstar
Twist Bioscience Corporation is a synthetic biology company that provides DNA synthesis and genomics solutions for research, healthcare, agriculture, and industrial biotechnology. Its silicon-based manufacturing platform produces synthetic DNA at high throughput, supporting applications that require precise, scalable biological materials. The company offers synthetic genes, oligonucleotide pools, next-generation sequencing target-enrichment products, sample-preparation tools, variant libraries, and synthetic RNA controls. It also provides antibody-discovery and biopharmaceutical services, helping researchers design, test, and develop biological molecules for therapeutic and diagnostic applications. Twist Bioscience Corporation serves pharmaceutical and biotechnology companies, academic institutions, agricultural organizations, and industrial customers. Its products and services contribute to drug discovery, genetic research, molecular diagnostics, precision medicine, crop science, and the development of bio-based chemicals. Through its combination of automated DNA production, laboratory tools, and specialized services, the company occupies an important role in the life-sciences supply chain by enabling the engineering and analysis of biological systems.